These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7569075)
21. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
22. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977 [TBL] [Abstract][Full Text] [Related]
23. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233 [TBL] [Abstract][Full Text] [Related]
24. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439 [TBL] [Abstract][Full Text] [Related]
25. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial. Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183 [TBL] [Abstract][Full Text] [Related]
26. Radiation therapy alone in elderly with early stage non-small cell lung cancer. San José S; Arnaiz MD; Lucas A; Navarro V; Serrano G; Zaderazjko M; Jeremic B; Guedea F Lung Cancer; 2006 May; 52(2):149-54. PubMed ID: 16516336 [TBL] [Abstract][Full Text] [Related]
27. Lung cancer and its operable brain metastasis: survival rate and staging problems. Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950 [TBL] [Abstract][Full Text] [Related]
28. High-dose-rate brachytherapy for small-sized peripherally located lung cancer. Imamura F; Ueno K; Kusunoki Y; Uchida J; Yoshimura M; Koizumi M; Yamasaki H; Nishiyama K Strahlenther Onkol; 2006 Dec; 182(12):703-7. PubMed ID: 17149576 [TBL] [Abstract][Full Text] [Related]
29. [Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients]. Ray-Coquard I; Bolla M; Reyt E; Brochon D; Lebeau J; Colonna M; Kolodié H; Vincent F; Chinal-Provencal J Bull Cancer; 1997 Sep; 84(9):863-8. PubMed ID: 9435807 [TBL] [Abstract][Full Text] [Related]
30. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Sura S; Yorke E; Jackson A; Rosenzweig KE Cancer J; 2007; 13(4):238-42. PubMed ID: 17762758 [TBL] [Abstract][Full Text] [Related]
31. [High-dose-rate brachytherapy. The indications, technic and preliminary results]. Orecchia R; Ragona R; Anglesio S; Tessa M; Del Mastro E; Sannazzari GL Minerva Med; 1996; 87(1-2):1-7. PubMed ID: 8610019 [TBL] [Abstract][Full Text] [Related]
32. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246 [TBL] [Abstract][Full Text] [Related]
34. [Clinical application of multiple fractions per day in lung and esophageal cancer]. Kikuchi Y Gan No Rinsho; 1988 Oct; 34(13):1773-82. PubMed ID: 2848956 [TBL] [Abstract][Full Text] [Related]
35. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases. Ghosh S; Sau S; Mitra S; Manna A; Ghosh K J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668 [TBL] [Abstract][Full Text] [Related]
36. High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers. Bartochowska A; Wierzbicka M; Skowronek J; Leszczyńska M; Szyfter W Brachytherapy; 2012; 11(2):137-43. PubMed ID: 22104354 [TBL] [Abstract][Full Text] [Related]
37. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Ricke J; Wust P; Wieners G; Hengst S; Pech M; Lopez Hänninen E; Felix R Chest; 2005 Jun; 127(6):2237-42. PubMed ID: 15947343 [TBL] [Abstract][Full Text] [Related]
38. HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer--comparison of two different dose schedules. Skowronek J; Kubaszewska M; Kanikowski M; Chicheł A; Młynarczyk W Radiother Oncol; 2009 Dec; 93(3):436-40. PubMed ID: 19854525 [TBL] [Abstract][Full Text] [Related]
39. A single-institutional brachytherapy experience in the management of esophageal cancer. Fabrini MG; Perrone F; De Liguoro M; Coppola M; Santi S; Solito B; Lencioni M; Rossi M; Cionini L Brachytherapy; 2010; 9(2):185-91. PubMed ID: 19875341 [TBL] [Abstract][Full Text] [Related]
40. Brachytherapy in the retreatment of patients with new primary head and neck cancer. Grimard L; Lamothe A; Esche B; Spaans JN J Otolaryngol; 2007 Dec; 36(6):327-35. PubMed ID: 18076842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]